Publicaciones en las que colabora con José Alberto Orfao de Matos Correia e Vale (14)

2014

  1. Research update for articles published in EJCI in 2012

    European Journal of Clinical Investigation, Vol. 44, Núm. 10, pp. 1010-1023

  2. Testosterone replacement therapy in hypogonadal men is associated with increased expression of LAMP-2 (CD107b) by circulating monocytes and dendritic cells

    Clinical Endocrinology, Vol. 80, Núm. 4, pp. 577-584

2012

  1. Enhanced immunological response by dendritic cells in male hypogonadism

    European Journal of Clinical Investigation, Vol. 42, Núm. 11, pp. 1205-1212

2009

  1. Persistence of androgenic effects on the production of proinflammatory cytokines by circulating antigen-presenting cells after withdrawal of testosterone treatment in aging type 2 diabetic men with partial androgen deficiency

    Fertility and Sterility, Vol. 92, Núm. 1, pp. 311-319

2007

  1. Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications

    Journal of Diabetes and its Complications, Vol. 21, Núm. 1, pp. 41-49

2006

  1. Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men and partial androgen deficiency

    Journal of Endocrinology, Vol. 189, Núm. 3, pp. 595-604

2004

  1. Partial Androgen Deficiency in Aging Type 2 Diabetic Men and Its Relationship to Glycemic Control

    Metabolism: Clinical and Experimental, Vol. 53, Núm. 5, pp. 666-672

2001

  1. The distribution of the major peripheral blood T, B and NK cell subsets does not predict the clinical outcome of Graves' disease patients after methimazole therapy

    Journal of Biological Regulators and Homeostatic Agents, Vol. 14, Núm. 3, pp. 193-199

1997

  1. Analysis of IL-2 and IL-6 binding to peripheral blood lymphocytes in Graves disease: Relationship with disease activity

    Communications in Clinical Cytometry, Vol. 30, Núm. 3, pp. 118-123

  2. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells

    Journal of Endocrinology, Vol. 155, Núm. 3, pp. 491-500

1996

  1. CD5+ B cells in Graves' disease: Correlation with disease activity

    Hormone and Metabolic Research, Vol. 28, Núm. 6, pp. 280-285

  2. Serial analysis of the effects of methimazole therapy on circulating B cell subsets in Graves' disease

    Journal of Endocrinology, Vol. 151, Núm. 2, pp. 231-240

1994

  1. The relationships between hyperthyroidism and the distribution of peripheral blood T, NK and B-lymphocytes in multinodular goiter

    Hormone and Metabolic Research, Vol. 26, Núm. 2, pp. 104-108

1993

  1. Immunological features of sporadic multinodular goiter

    The Clinical Investigator, Vol. 71, Núm. 7, pp. 552-558